文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

中国史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症的流行病学。

The Epidemiology of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in China.

机构信息

Department of Dermatology, Xiamen Chang Gung Hospital, Xiamen, Fujian, China.

Department of Dermatology, Chang Gung Memorial Hospital, Chang Gung University, Taoyuan, Taiwan.

出版信息

J Immunol Res. 2018 Feb 11;2018:4320195. doi: 10.1155/2018/4320195. eCollection 2018.


DOI:10.1155/2018/4320195
PMID:29607330
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5828103/
Abstract

Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS/TEN) are life-threatening disease. However, there are only few epidemiologic studies of SJS/TEN from China. To analyze the clinical characteristics, causality, and outcome of treatment for SJS/TEN in China, we reviewed case reports of patients with SJS/TEN from the China National Knowledge Infrastructure (CNKI) and Wanfang database from 2006 to 2016 and patients with SJS/TEN who were admitted to the First Affiliated Hospital of Fujian Medical University during the same period. There were 166 patients enrolled, including 70 SJS, 2 SJS/TEN overlap, and 94 TEN. The most common offending drugs were antibiotics (29.5%) and anticonvulsants (24.1%). Carbamazepine, allopurinol, and penicillins were the most common single offending drugs (17.5%, 9.6%, and 7.2%). Chinese patent medicines accounted for 5.4%. There were 76 (45.8%) patients receiving systemic steroid and intravenous immunoglobulin (IVIG) in combination therapy, especially for TEN (80.3%), and others were treated with systemic steroids alone. Mortality rate of combination treatment comparing with steroid alone in TEN patients had no statistical significance. In conclusion, carbamazepine and allopurinol were the leading causative drugs for SJS/TEN in China. Combination of IVIG and steroids is a common treatment for TEN, but its efficacy in improving mortality needs further investigation.

摘要

史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症(SJS/TEN)是危及生命的疾病。然而,来自中国的 SJS/TEN 仅有少数流行病学研究。为了分析中国 SJS/TEN 的临床特征、病因和治疗结果,我们回顾了 2006 年至 2016 年期间中国国家知识基础设施(CNKI)和万方数据库中 SJS/TEN 病例报告和同期福建医科大学第一附属医院 SJS/TEN 住院患者。共纳入 166 例患者,其中 SJS 70 例,SJS/TEN 重叠 2 例,TEN94 例。最常见的致病药物为抗生素(29.5%)和抗惊厥药(24.1%)。卡马西平、别嘌呤醇和青霉素为最常见的单一致病药物(17.5%、9.6%和 7.2%)。中成药占 5.4%。76 例(45.8%)患者接受了包括静脉注射免疫球蛋白(IVIG)和全身类固醇在内的联合治疗,特别是 TEN(80.3%),其他患者接受了全身类固醇单独治疗。与 TEN 患者单独使用类固醇相比,联合治疗的死亡率无统计学意义。总之,卡马西平和别嘌呤醇是中国 SJS/TEN 的主要致病药物。IVIG 和类固醇的联合治疗是 TEN 的常用治疗方法,但改善死亡率的疗效需要进一步研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a5d/5828103/073ceb37d9fb/JIR2018-4320195.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a5d/5828103/eccf46f1c618/JIR2018-4320195.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a5d/5828103/073ceb37d9fb/JIR2018-4320195.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a5d/5828103/eccf46f1c618/JIR2018-4320195.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a5d/5828103/073ceb37d9fb/JIR2018-4320195.002.jpg

相似文献

[1]
The Epidemiology of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in China.

J Immunol Res. 2018-2-11

[2]
Combination therapy of intravenous immunoglobulin and corticosteroid in the treatment of toxic epidermal necrolysis and Stevens-Johnson syndrome: a retrospective comparative study in China.

Int J Dermatol. 2009-10

[3]
Profile and pattern of Stevens-Johnson syndrome and toxic epidermal necrolysis in a general hospital in Singapore: treatment outcomes.

Acta Derm Venereol. 2012-1

[4]
Retrospective study of 213 cases of Stevens-Johnson syndrome and toxic epidermal necrolysis from China.

Burns. 2020-6

[5]
A Retrospective Cohort Study of the Management and Outcomes of Children Hospitalized with Stevens-Johnson Syndrome or Toxic Epidermal Necrolysis.

J Allergy Clin Immunol Pract. 2018-5-30

[6]
High-dose intravenous immunoglobulins in the treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis in Chinese patients: a retrospective study of 82 cases.

Eur J Dermatol. 2010-10-15

[7]
Clinical characteristics of childhood erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis in Taiwanese children.

J Microbiol Immunol Infect. 2004-12

[8]
Efficacy of additional i.v. immunoglobulin to steroid therapy in Stevens-Johnson syndrome and toxic epidermal necrolysis.

J Dermatol. 2015-8

[9]
Retrospective analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis in 87 Japanese patients--Treatment and outcome.

Allergol Int. 2016-1

[10]
A 10-year retrospective cohort study of the management of toxic epidermal necrolysis and Stevens-Johnson syndrome in a New South Wales state referral hospital from 2006 to 2016.

Int J Dermatol. 2019-3-25

引用本文的文献

[1]
The Prevalence of Stevens-Johnson Syndrome Complications due to Antiepileptic Drug Use: A Systematic Review and Meta-Analysis.

Int J Prev Med. 2025-7-30

[2]
Updates in the pathogenesis of SJS/TEN.

Allergol Int. 2025-7

[3]
Liver Injury in Immune Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Five New Classification Types.

J Clin Transl Hepatol. 2025-4-28

[4]
Co-Trimoxazole-Induced Toxic Epidermal Necrolysis: A Case Report From Nepal.

Clin Case Rep. 2024-11-29

[5]
Role of neutrophil-lymphocyte ratio as a prognostic marker in SJS/TEN patients.

Arch Dermatol Res. 2024-8-23

[6]
Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Analysis of the Russian Database of Spontaneous Reports.

Pharmaceuticals (Basel). 2024-5-24

[7]
Emerging Insights into Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Induced by Immune Checkpoint Inhibitor and Tumor-Targeted Therapy.

J Inflamm Res. 2024-4-17

[8]
Identifying the most at-risk age-group and longitudinal trends of drug allergy labeling amongst 7.3 million individuals in Hong Kong.

BMC Med. 2024-1-26

[9]
Drug-Induced Anaphylaxis: National Database Analysis.

Pharmaceuticals (Basel). 2024-1-9

[10]
Chemotherapy-induced toxic epidermal necrolysis in a patient with multiple myeloma, a case report and literature review.

Front Oncol. 2023-8-2

本文引用的文献

[1]
Successful Use of Cyclosporin A for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Three Children.

Pediatr Dermatol. 2017-9

[2]
Cyclosporine Use in Epidermal Necrolysis Is Associated with an Important Mortality Reduction: Evidence from Three Different Approaches.

J Invest Dermatol. 2017-6-17

[3]
Effectiveness, safety and tolerability of cyclosporine versus supportive treatment in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A record-based study.

Indian J Dermatol Venereol Leprol. 2017

[4]
Systemic Immunomodulating Therapies for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Systematic Review and Meta-analysis.

JAMA Dermatol. 2017-6-1

[5]
The Epidemiology of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in the UK.

J Invest Dermatol. 2017-6

[6]
Epidemiology and Molecular Characteristics of Mycoplasma pneumoniae During an Outbreak of M. pneumoniae-associated Stevens-Johnson Syndrome.

Pediatr Infect Dis J. 2017-6

[7]
Interleukin-15 Is Associated with Severity and Mortality in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis.

J Invest Dermatol. 2017-5

[8]
Risk and association of HLA with oxcarbazepine-induced cutaneous adverse reactions in Asians.

Neurology. 2017-1-3

[9]
Severe Cutaneous Adverse Reactions: The Pharmacogenomics from Research to Clinical Implementation.

Int J Mol Sci. 2016-11-15

[10]
Severe cutaneous adverse drug reactions.

J Dermatol. 2016-7

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索